We have previously obtained strong evidence for linkage of mild malaria attack to the MHC region, with a peak close to the tumor necrosis factor (TNF) gene. We screened, for polymorphisms, the entire TNF gene in the same sample of 34 families comprising 197 individuals living in a Plasmodium falciparum endemic area and we found 17 polymorphisms. In a longitudinal study, we investigated whether the 11 most frequent and informative polymorphisms were associated with mild malaria attack and maximum parasitemia, which was the highest parasitemia in each individual over 2 years. Mild malaria attack and maximum parasitemia were positively correlated. Transmission disequilibrium tests showed nominal evidence for association between TNF-1031, TNF-308, TNF851 and TNF1304 polymorphisms, and mild malaria attack on the one hand, and between TNF-238, TNF851 and TNF1304 polymorphisms, and maximum parasitemia on the other hand. After accounting for multiple tests, we confirmed the association of TNF-238 with maximum parasitemia and the association of TNF1304 and TNF851 with maximum parasitemia and mild malaria attack. The association tests with mild malaria attack suggest a moderate effect of TNF-308 polymorphism. In conclusion, our study suggests that several TNF variants may be part of the genetic determinants for maximum parasitemia and/or mild malaria attack.
Introduction
Malaria is the most common parasitic disease in developing countries. According to World Health Organization estimates, between 300 and 500 million clinical cases occur each year worldwide. Mortality due to malaria ranges from 1.5 million to 2.7 million deaths per year. Both parasite and host genetic factors contribute to the disease. To find human genes involved in malarial disease and infection, candidate gene studies and candidate chromosomal region analyses have been performed. Case-control studies have detected the association of severe malaria with several genes, including genes within the MHC complex. In particular, polymorphisms in the tumor necrosis factor (TNF) gene have been associated with increased susceptibility to severe malaria. [1] [2] [3] [4] Furthermore, genetic analyses of sibling pairs evidenced linkage of mild malaria to the MHC region, with a peak close to the TNF locus. 5, 6 These findings are consistent with biological evidence for the role of TNFa in human malaria. As high TNFa plasma levels have been associated with increased susceptibility to severe malaria, 7, 8 anti-TNFa therapy inhibits fever in children with cerebral malaria, 9 and high TNFa production capacity during the acute phase of malaria has been associated with accelerated cure in Plasmodium falciparum malaria, 10 TNFa is thought to be a critical factor in malaria pathogenesis and in the control of parasitemia. TNFa acts as a pyrogenic and proinflammatory molecule and is involved in the killing of P. falciparum mediated by neutrophils and monocytes in the presence of antibodies. 11, 12 This raises the question of whether variation in the TNFa gene may explain differences in phenotypes related to malaria infection and mild disease. To address this issue, Stirnadel et al 13 and Migot-Nabias et al 14 studied polymorphisms at the TNF-308 and TNF-238 position. Using a case-control and cross-sectional design, they did not detect association of TNF polymorphisms with mild malaria or parasitemia. [13] [14] [15] In order to identify polymorphisms that might be associated with mild malaria and related phenotypes, we systematically screened the TNF gene in an urban population living in an endemic area in Burkina Faso.
We surveyed 197 individuals from 34 families over 2 years, and we evaluated linkage and association of TNF polymorphisms with mild malaria and parasitemia.
Results

Screening of TNF variants
We analyzed global genetic variation in TNF by denaturing high-performance liquid chromatography (DHPLC), and we identified variants by direct sequencing. In all, 16 fragments representing the entire sequence of the TNF gene were submitted to DHPLC analysis in the parents (n ¼ 51). In case of unavailable DNA from the father or the mother, we analyzed DNA from all the children (n ¼ 44). We sequenced all the PCR products, for which we obtained evidence of heteroduplexes. We further screened by DHPLC the TNF gene in all the children, the parents of whom had at least one variant, and we checked the presence of the variant by sequencing. This strategy was efficient for all but the tnf6 fragment ( Table 1 ). For that PCR product, we detected only one single-nucleotide polymorphisms (SNP) by DHPLC and we identified two SNPs by sequencing. In addition, we found that the same individuals generally carried the mutant form of the two SNPs. Therefore, we sequenced the tnf6 PCR product to identify and genotype the variants in the whole sample.
We identified 17 TNF genetic polymorphic sites across a 3.6-kb segment in the TNF gene ( Figure 1 ). All the variants were previously reported (http://hgvbase.cgb. ki.se and http://www.ncbi.nlm.nih.gov./SNP/). Although we clearly identified TNF-376 in a control sample, we did not detect this mutation in the study population . Of the  17 polymorphic sites, six had a low genetic information  content: TNF-163 G4A, TNF420 G4A, TNF472 G4A,  TNF489 G4A, TNF2053 A4C , and a four nucleotide insertion/deletion À/TGAA. At these polymorphic sites, the rare allele had a frequency o0.01, and the power of association analysis was too small for these SNPs. Therefore, these SNPs were excluded from further analyses.
The most common variants, with the exception of a two-nucleotide insertion/deletion polymorphism, were SNPs ( Table 1) . Most of the mutations were clustered in the promoter region (Figure 1 ). Three mutations were found in introns and only one was located within an exon. The G4T transversion at position 267 in exon 1 was synonymous.
All genotypes passed a Mendelian check with the program Pedchek. Using MERLIN, we further searched for improbable recombination events from dense SNP maps to detect genotyping errors. The detectable genotype errors in the sample were o0.2%. Genotype coverage was always 488%. There was no deviation from the Hardy-Weinberg equilibrium (P40.5). The frequency of the variant allele is shown. Figure 1 Location of the polymorphisms detected within the TNF gene. The intron ( )/exon ( ) structure of the gene is shown.
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Linkage disequilibrium
We generated haplotypes by the method of Abecasis et al 16 , using the genotype data of 11 polymorphic sites ( Table 1) . As shown in Table 2 , 15 haplotypes could be inferred. We then calculated pairwise disequilibrium coefficients for the 11 genetic markers. As shown in Table 3 , we found significant linkage disequilibrium between several variants. In particular, TNF851 and TNF1304 were in strong linkage disequilibrium. Conversely, no variant was in linkage disequilibrium with TNF-308.
Association with mild malaria and maximum parasitemia We surveyed 197 individuals from 34 families during 2 years. Individuals who had at least one mild malaria attack during the study were considered affected. We also determined the highest parasitemia in each individual over 2 years. A logistic regression analysis showed that mild malaria attack negatively correlated with age (Po0.0001). Similarly, a multiple linear regression analysis revealed a negative correlation between maximum parasitemia and age (Po0.0001), and a positive correlation between maximum parasitemia and the number of measurements (Po0.0001). Therefore, in further analyses, both phenotypes were corrected accordingly. In addition, there was a positive correlation between mild malaria attack and maximum parasitemia (Po0.0001).
We performed combined linkage and association analysis at each of the 11 most frequent TNF variants. To analyze the genetic basis of mild malaria attack and maximum parasitemia, we performed transmission disequilibrium test (TDT) analyses using the QTDT program. Table 4 summarizes association results. TNF-1031, TNF-308, TNF-238, TNF851 and TNF1304 showed nominal evidence for association (Po0.05). We evidenced association of mild malaria attack with TNF-1031, TNF-308, TNF851 and TNF1304. In addition, we obtained evidence for association of maximum parasitemia with TNF-238, TNF851 and TNF1304.
The strongest observed association at this stage (P ¼ 0.0005) occurs at TNF-238. To account for multiple tests performed, we applied a procedure that makes use of the correlation information. 17 Overall, the probability of observing an association as strong as the one presented here was Pc ¼ 0.0028. Similarly, we evidenced association of TNF851 with parasitemia (Pc ¼ 0.028) and mild malaria attack (Pc ¼ 0.028). We also obtained significant Pc values when analyzing association of TNF1304 with maximum parasitemia (Pc ¼ 0.018) and mild malaria attack (Pc ¼ 0.022). Thus, the null hypothesis that there was no association between TNF variants Table 2 Haplotypes for the most common polymorphisms of the TNF gene
Identifier
Haplotype Frequency
The order of polymorphisms from left to right in the genomic order as listed in Table 1 . To dissect the pattern of association between TNF polymorphisms and malaria-related phenotypes, we carried out a procedure in which SNPs were included as covariates in the linkage and association analysis. We included in the model the most significantly associated SNPs (Table 4) and SNPs in linkage disequilibrium (Table 3) to test whether association could be due to linkage disequilibrium and whether the other markers could account for any further variation in malaria-related phenotypes.
The association of TNF-238 with maximum parasitemia did remain after adjusting for the effect of TNF1304 (P ¼ 0.006; Pc ¼ 0.032), TNF851 (P ¼ 0.0006; Pc ¼ 0.0027) or TNF-1031 (P ¼ 0.0009; Pc ¼ 0.0052). When TNF1304, TNF851 and TNF-1031 were simultaneously included as covariates, TNF-238 was strongly associated with parasitemia (P ¼ 0.00007; Pc ¼ 0.00039). In contrast, there was no association of TNF1304 and TNF851 with maximum parasitemia when TNF-238 was taken into account. Besides, with this adjustment, tnf2395 was nominally associated with maximum parasitemia (P ¼ 0.025); the association was no longer significant after adjusting for multiple comparisons. Similarly, when we adjusted for TNF1304, we did not detect nominal association of mild malaria attack with TNF851, and we obtained nominal evidence for association of mild malaria attack with TNF-1031 (P ¼ 0.04) and TNF-308 (P ¼ 0.018), the association being not significant when it was corrected for multiple testing. Interestingly, the association of TNF-308 with mild malaria attack yielded significant P-values after adjusting for TNF-1031, TNF851 and TNF1304 (P ¼ 0.002; Pc ¼ 0.015).
To test whether SNPs were specifically associated with either maximum parasitemia or mild malaria attack, we included maximum parasitemia or mild malaria attack as a covariate. The association of maximum parasitemia with TNF-238 remained when we included mild malaria attack as a covariate (P ¼ 0.0045; Pc ¼ 0.025); a similar result was obtained when we simultaneously took into account TNF-1031, TNF851 and TNF1304 polymorphisms, and mild malaria attack (P ¼ 0.005; Pc ¼ 0.034).
Conversely, the association of TNF1304 with mild malaria attack was no longer significant after adjusting for maximum parasitemia (P ¼ 0.051). Interestingly, with this adjustment, TNF-308 was nominally associated with mild malaria attack (P ¼ 0.008; Pc ¼ 0.056). The association of TNF-308 with mild malaria attack was significant when we included TNF-1031, TNF851 and TNF1304, and parasitemia as covariates (P ¼ 0.0049; Pc ¼ 0.033).
Discussion
In the present study, we have investigated the contribution of genetic variations in TNF to phenotypes related to malaria infection and mild disease. We used a combined strategy of extensive mutation screening in individuals living in an endemic area and subsequent family-based association analysis.
In our population, variation occurred at 17 polymorphic sites. All the polymorphisms were previously described, and allele frequencies reported in Africa by us and by others 18, 19 were similar. Of the 17 polymorphic sites, six sites with low allele frequency and with low genetic information content were excluded from association analysis. Our study provides evidence that there were three single-nucleotide variants associated with maximum parasitemia and/or mild malaria attack. A nominal association of TNF-1031 and TNF-308 with mild malaria attack was also noticed, but the effect of these SNPs disappeared when we adjusted for multiple testing. Nevertheless, our results clearly support the idea that variation in the TNF gene influences both maximum parasitemia and the occurrence of mild malaria attack. Therefore, there is a convergence of association and biological evidence, 9, 11, 12, 20 indicating a crucial role of TNF in mild malaria and in the control of parasitemia.
Strikingly, TNF-238A, which has been associated with protection from cerebral malaria in Kenya, 2 was, in our study, associated with reduced maximum parasitemia. There was also a trend in favor of the association between TNF-238A and a reduced risk of mild malaria attack. However, the result was not significant, as found 
14 These findings suggest that the TNF-238 polymorphism may be functional and causal. In this way, TNF-238A was found to be associated with increased levels of antibodies directed against P. falciparum antigens.
14 In addition, IL10 : TNFa plasma level ratio negatively correlated to parasitemia and a low ratio was associated with TNF-238A, suggesting that TNF-238 polymorphism alters the balance between the antiinflammatory cytokine IL10 and the proinflammatory cytokine TNFa. 21 Direct functional studies provided contrasting results since Drouet et al 22 did. Besides, replacing 10 bp covering the TNF-238 region with an irrelevant sequence increased basal transcription. 25 Interestingly, it has been suggested that the TNF-238 region contains a repressor site. 26 Similarly, discrepant results have been obtained, [27] [28] [29] and it is not clear whether the TNF-308 polymorphism influences TNF expression. In addition, association analyses of TNF-308 with malaria do not give a clear picture. TNF-308A has been found to be associated with susceptibility to severe malaria by several authors. 1, 2, 30, 31 In the same way, symptomatic P. falciparum reinfection occurred, in Gabon, more quickly in TNF-308A carriers (with severe malaria at enrolment) compared with carriers of other promoter variants. 32 Using a casecontrol design, Stirnadel et al 13 did not find, however, significant association of TNF-308 polymorphism with mild malaria attack in Tanzania. Here, we report a nominal association of TNF-308A with protection to mild malaria attack, although the effect of TNF-308A was no longer significant when we adjusted for multiple testing. The association of the TNF-308 polymorphism with mild malaria attack yielded, however, a significant P-value when we took into account the effect of TNF-1031, TNF851 and TNF1304 polymorphisms. Taken together, these discrepant findings suggest that TNF-308A may be not a causal mutation, and that TNF-308A may be in linkage disequilibrium with a causal mutation close to the TNF gene. 33 Alternatively, the TNF-308 polymorphism may have a moderate effect or may act epistatically with other mutations. Other studies should be conducted to clarify this issue. In particular, it remains to evaluate whether combination of several particular alleles in the TNF promoter, including TNF-308A, significantly alters TNF expression.
Unlike the TNF-308 polymorphism, we found that TNF1304A and TNF851A were significantly associated with increased maximum parasitemia and increased risk of mild malaria attack. There is no report on the influence of these intronic polymorphisms on TNF expression. It is not known whether the TNF1304 and TNF851 polymorphisms are located within regulatory regions, donor or acceptor splice sites, or splicing enhancer or silencer sites. Therefore, it remains to investigate both quantitative and qualitative effects of the TNF1304 and TNF851 polymorphisms on TNF expression. Nevertheless, we cannot exclude the fact that TNF1304 or TNF851 may serve as a marker for functional polymorphism elsewhere in another nearby gene and/or in the TNF gene. In this way, we found that TNF1304 or TNF851 were no longer associated with parasitemia when we took into account the effect of the TNF-238 polymorphism.
Since individuals with high maximum parasitemia had enhanced risk of mild malaria attack, it is expected that some TNF variants are associated with both increased maximum parasitemia and increased risk of malaria attack. In this way, there was a trend in favor of the association between TNF-1031T and both maximum parasitemia and risk of malaria attack. Moreover, TNF1304A and TNF851A were significantly associated with increased maximum parasitemia and increased risk of mild malaria attack. In contrast, the TNF-308 polymorphism may be associated with mild malaria attack, but not with maximum parasitemia. Similarly, TNF-238A was strongly associated with reduced parasitemia, and did not seem to be associated with reduced risk of mild malaria attack. In addition, the association of maximum parasitemia was significant when we included mild malaria attack as a covariate. These findings highlight the complexity of the relationship between TNF polymorphisms and different phenotypes related to malaria. Similarly, McGuire et al 1, 3 found in a population living in The Gambia that TNF-308A was associated with cerebral malaria, but not with severe malarial anemia, and that TNF-238A was associated with severe malarial anemia, but not with cerebral malaria. It has been assumed that the chronic low-grade production of TNFa induces dyserythropoiesis and contributes to the pathogenesis of malarial anemia, while an acute production of TNFa in the brain acts to upregulate endothelial adhesiveness, promotes sequestration and therefore contributes to the pathogenesis of cerebral malaria. Here, we propose that low-grade and targeted TNFa production efficiently protects from the parasite without reaching the pyrogenic threshold. In particular, TNFa production in TNF-238A carriers may be higher than TNFa production in TNF-238G carriers, and may be sufficient for parasite killing without causing mild malaria attack. This hypothesis is consistent with the existence of a repressor site in the TNF-238 region, 26 the inhibition effect of which might be altered by the TNF-238A variant.
Although we found several associations between TNF variants and phenotypes related to malaria infection and mild disease, we do think that other genes lying within the MHC region are involved in controlling parasitemia and disease. It should be stressed that the TNF allele frequencies were not high and those TNF polymorphisms per se probably do not explain linkage of mild malaria to the MHC region. 5, 6 In particular, other immunologically relevant genes such as LTA, HLA-B and HLA-DR should be considered as candidate genes. This raises the possibility that haplotypes combining particular alleles of such genes could protect against the parasite or could lead to malarial disease.
In conclusion, from our study, several TNF variants were found to be associated with phenotypes related to malaria infection and mild disease, and may be part of the genetic determinants for human malaria resistance/susceptibility. Replication studies and functional analyses are required to further validate our findings. In addition, other candidate genes within the MHC region should be screened in order to identify new polymorphisms associated with parasitemia or clinical malaria.
Materials and methods
Subjects
In all, 197 probands from 34 families were collected in an endemic area in Burkina Faso. 6 The families had the following distribution of sibship sizes: 3, 12, 8, 8, 2 and 1 sibships contained 2, 3, 4, 5, 6 and 7 sibs, respectively. The mean age of sibs was 12.176.2 years (range 1-34 years). The study population and the area of parasite exposure have been described. 34 The seasonal parasite transmission intensity was homogeneous within the area. The whole population volunteered to participate in the study, and all participants were clearly informed of the objective and the protocol. The Medical Authority of Burkina Faso approved the study protocol.
Phenotyping Determination of parasitemia was described in our previous study. 34 Briefly, each family was visited 20 times during the 24 months of the study, and parasitemia was measured. In addition, parasitemia was measured during febrile episodes. The mean number of parasitemia measurements per subject was 15.275.1 (range 1-24). Fingerprint peripheral blood samples were taken from all family members present and thick and thin blood films were stained with Giemsa. The parasite determination and numeration were established blindly from two independent readings. Only P. falciparum asexual forms were retained to determine parasitemia. Parasitemia was defined as the number of parasitized erythrocytes observed per ml in thin blood films.
The first phenotype (maximum parasitemia) was based on a logarithmic transformation of the highest parasitemia in each individual. Multiple polynomial regression was carried out with age and the number of measurements. The explicative variables were treated as continuous variables. The analysis revealed that age and the number of measurements had an effect on maximum parasitemia (P ¼ 0.0001). We took into account age and the number of measurements in association and linkage analyses.
Febrile episodes were extensively recorded by active case detection during 24 months. For patients with fever, a thick blood film was prepared by the standard procedures. According to the WHO, diagnosis of mild malaria attack was based on P. falciparum parasitemia, fever (axillary temperature more than 37.51C), and clinical symptoms (headache, aching, vomiting or diarrhea in the children); in that case no threshold of parasitemia was used. Since the risk of febrile illness rises with parasitemia, 35 the WHO committee also recommended the use of a specified parasitemia threshold. In the absence of classical symptoms of malaria, we used an age-dependent parasitemia threshold: 36 only children (age o15 years) with more than 5000 parasites per ml and older subjects with more than 2000 parasites per ml were considered as having had a malaria attack. According to the recommendation of the CNRFP (Centre National de Recherche et Formation sur le Paludisme) of Burkina Faso, each episode of illness was treated with 25 mg/kg chloroquine during 3 days or until recovery. Parasitemia was checked at the end of the treatment. In all, 59 individuals (four parents and 55 sibs) presented at least one mild malaria attack during the survey. After treatment, these individuals had neither parasite nor fever. They were considered in the analysis as affected individuals. Sibs from five families were unaffected. In all, 11, 12, 5 and 1 families contained 1, 2, 3 and 5 affected sibs, respectively.
The second phenotype was based on the risk of developing malaria attacks. To take into account the influence of known covariates on the phenotype, we performed logistic regression. Since age and hemoglobin genotype are known to influence the development of malaria attacks, we adjusted the logit of the probability P of malaria attack for age and hemoglobin genotype. 37 The residual of the logistic regression model was then recoded into deciles. We calculated a phenotype value for each sib. All the sibs were included in linkage and association analysis.
A logistic regression analysis and a multiple regression analysis showed that mild malaria attack and parasitemia were positively correlated (Po0.0001). ATATCTCCCAGGAGCTCCCT  60  251  tnf2  AGGGAGCTCCTGGGAGATAT  GGGGTCCCTGATTTTTTTCA  60  284  tnf3  GGTATGGAATACAGGGGACG  AGGCCTCAGGAAAGGCTG  60  256  tnf4  GTCCAGGCTTGTCCTGCTAC  CCCCTCAAAACCTATTGCCT  63  276  tnf5  AGGCAATAGGTTTTGAGGGG  AACCAGCGGAAAACTTCCTT  59  267  tnf6  GAAACCGAGACAGAAGGTGC  GAAGCCGTGGGTCAGTATGT  62  306  tnf7  GGCAGGTTCTCTTCCTCTCA  GCACTCACCTCTTCCCTCTG  63  259  tnf8  CAGAGGGAAGAGGTGAGTGC  CCCCCATCTCTCTTCTCACA  63  337  tnf9  TGTGAGAAGAGAGATGGGGG  TGTTGGGGAGAAGGAGAATG  60  301  tnf10  CATTCTCCTTCTCCCCAACA  GGGCTACAGGCTTGTCACTC  62  293  tnf11  GGATCATCTTCTCGAACCCC  GCACCACCAGCTGGTTATCT  62  449  tnf12  AGATAACCAGCTGGTGGTGC  ATGTTCGTCCTCCTCACAGG  62  356  tnf13  ATTGCCCTGTGAGGAGGAC  GAGGAAGGCCTAAGGTCCAC  62  387  tnf14  GGGAGCCTTTGGTTCTGG  TTGGGTCCCCCAGGATAC  58  254  tnf15  TATTTGGGAGACCGGGGTAT  GCCACTAATAGTAGGGCGA  60  262  tnf16  TCGCCCTACTATTCAGTGGC  GCCCTGAGGGAGAGGTAATT  62  265 All computations were carried out with SPSS software (SPSS, Boulogne, France). Tests of the hypothesis that a regression coefficient was 0 were carried out with the Wald w 2 statistic for logistic regression and Student's t test for multiple polynomial regression. Only terms significant at the 5% level were retained.
DNA analysis (DNA extraction, PCR, DHPLC, sequencing) DNA was extracted from mononuclear cells separated by the Ficoll-Hypaque density gradient as described. 34 Samples were first subject to prior whole genome amplification by primer extension preamplification. 38 To screen the entire TNF gene for mutations, we performed DHPLC analysis of 16 defined PCR products. In all, 16 primer pairs were designed with the PRIMER program ( Table 5 ) (Human Genome Mapping Project, http://menu.hgmp.mrc.ac.uk). The DNA fragments were amplified individually. PCR amplification was carried out with AmpliTaq (PE Biosystems) in 80 ml reactions, using a Hybaid apparatus. Thermocycling started with a single denaturation step for 5 min at 951C, following 35 cycles of denaturation for 40 s at 951C, annealing for 30 s and extension at 721C for 10 s. One final extension step was added for 10 min at 721C. The PCR products were checked by 2% agarose gel electrophoresis before DHPLC analysis, to make sure that only the specific product was amplified.
DHPLC was carried out on a WAVE DNA fragment analysis system (Transgenomic, Crewe, UK). The PCR products were denatured at 951C for 5 min, and were allowed to reanneal from 95 to 241C over 70 min. The PCR products were injected into the column and were separated (flow rate of 0.9 ml/min) through a linear acetonitrile gradient. The start concentrations of buffer B are listed in Table 6 . The gradient was generated by increasing the concentration of buffer B (0.1 M triethylammonium acetate, 25% acetonitrile) relative to buffer A (0.1 M triethylammonium acetate). The buffer gradient for each amplicon was determined with the Wavemaker software version 4.1. The oven temperatures for optimal heteroduplex separation were also determined with the software, which gives a computer-assisted determination of melting profile for each fragment. Where distinct domains were predicted, DHPLC analysis was performed at two or more different temperatures (Table 6 ). Polymorphisms were identified by sequencing PCR products with the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Qiagen) and an ABI 310 automated fluorescent sequencer (PE Biosystems). In addition, we could compare results previously obtained by SSCP 6 with DHPLC patterns. The genotypes at the loci TNF-308, TNF-244, TNF-238 and TNF-163 were fully confirmed.
Allele frequencies, haplotype reconstruction and linkage disequilibrium analysis Allele frequencies were calculated by gene counting, and deviation from Hardy-Weinberg equilibrium was tested using a w 2 with 1 df. We generated haplotypes on the basis of family genotypic data with GENEHUNTER. Pairwise linkage disequilibrium was calculated with GOLD (Graphical Overview of Linkage Disequilibrium). 39 We tested linkage disequilibrium between pairs of biallelic markers by the r 2 statistic:
where f11, f22, f12 and f21 were two-locus haplotype frequencies, and p1, p2, q1 and q2 were allele frequencies. r 2 is the standard w 2 statistic divided by the number of chromosomes in the sample. It ranges from 0 to 1. Linkage and association analysis We carried out combined association and linkage analyses of quantitative traits using the orthogonal model released in the QTDT 2.4.3 program. 40 Variance components are used to construct a test that utilizes information from all available offspring. The orthogonal model partitions association into between-and withinfamily components, and allowed the use of markers and phenotypes as covariates in analyses. Evidence of association can be evaluated by the likelihood-ratio test (null hypothesis likelihood L0 vs alternative hypothesis likelihood L1). Asymptotically, the quantity 2(LnL1-LnL0) is distributed as w 2 with df equal to the difference in the number of parameters estimated.
The Bonferroni correction procedure is used to account for multiple independent association tests. The Bonferroni correction procedure does not take into account allelic association and correlation between phenotypes. We therefore used a procedure that makes use of the correlation information. 17 Briefly, the adjusted significance level and the observed corrected Pc value are ak ¼ 1 À ð1 À aÞ 1=mk and Pck ¼ 1 À ð1 À pkÞ mk , respectively, where mk ¼ K 1Àrk and rk ¼ ( P rjk)/(KÀ1), and rjk is the correlation coefficient between the jth and the kth parameter. When the average of the correlation coefficient is zero, the adjustment is according to the Bonferroni test, and when it is one, the unadjusted and the adjusted P-values are the same. To account for allelic association, we used the r value (Table 3) .
